These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27391469)

  • 1. Oxidation of Са2+-Binding Domain of NADPH Oxidase 5 (NOX5): Toward Understanding the Mechanism of Inactivation of NOX5 by ROS.
    Petrushanko IY; Lobachev VM; Kononikhin AS; Makarov AA; Devred F; Kovacic H; Kubatiev AA; Tsvetkov PO
    PLoS One; 2016; 11(7):e0158726. PubMed ID: 27391469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the binding site for the regulatory calcium-binding domain in the catalytic domain of NOX5.
    Tirone F; Radu L; Craescu CT; Cox JA
    Biochemistry; 2010 Feb; 49(4):761-71. PubMed ID: 20028137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The emerging role of NADPH oxidase NOX5 in vascular disease.
    Jha JC; Watson AMD; Mathew G; de Vos LC; Jandeleit-Dahm K
    Clin Sci (Lond); 2017 May; 131(10):981-990. PubMed ID: 28473473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ROS signaling by NADPH oxidase 5 modulates the proliferation and survival of prostate carcinoma cells.
    Höll M; Koziel R; Schäfer G; Pircher H; Pauck A; Hermann M; Klocker H; Jansen-Dürr P; Sampson N
    Mol Carcinog; 2016 Jan; 55(1):27-39. PubMed ID: 25559363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NOX5 is expressed at the plasma membrane and generates superoxide in response to protein kinase C activation.
    Serrander L; Jaquet V; Bedard K; Plastre O; Hartley O; Arnaudeau S; Demaurex N; Schlegel W; Krause KH
    Biochimie; 2007 Sep; 89(9):1159-67. PubMed ID: 17587483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NOX5 NAD(P)H oxidase regulates growth and apoptosis in DU 145 prostate cancer cells.
    Brar SS; Corbin Z; Kennedy TP; Hemendinger R; Thornton L; Bommarius B; Arnold RS; Whorton AR; Sturrock AB; Huecksteadt TP; Quinn MT; Krenitsky K; Ardie KG; Lambeth JD; Hoidal JR
    Am J Physiol Cell Physiol; 2003 Aug; 285(2):C353-69. PubMed ID: 12686516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NOX5: from basic biology to signaling and disease.
    Bedard K; Jaquet V; Krause KH
    Free Radic Biol Med; 2012 Feb; 52(4):725-34. PubMed ID: 22182486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human monocytes and macrophages express NADPH oxidase 5; a potential source of reactive oxygen species in atherosclerosis.
    Manea A; Manea SA; Gan AM; Constantin A; Fenyo IM; Raicu M; Muresian H; Simionescu M
    Biochem Biophys Res Commun; 2015 May; 461(1):172-9. PubMed ID: 25871798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NADPH oxidase 5 (NOX5) interacts with and is regulated by calmodulin.
    Tirone F; Cox JA
    FEBS Lett; 2007 Mar; 581(6):1202-8. PubMed ID: 17346712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor activation of NADPH oxidases.
    Petry A; Weitnauer M; Görlach A
    Antioxid Redox Signal; 2010 Aug; 13(4):467-87. PubMed ID: 20001746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NOX5 variants are functionally active in endothelial cells.
    BelAiba RS; Djordjevic T; Petry A; Diemer K; Bonello S; Banfi B; Hess J; Pogrebniak A; Bickel C; Görlach A
    Free Radic Biol Med; 2007 Feb; 42(4):446-59. PubMed ID: 17275676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nox5 forms a functional oligomer mediated by self-association of its dehydrogenase domain.
    Kawahara T; Jackson HM; Smith SM; Simpson PD; Lambeth JD
    Biochemistry; 2011 Mar; 50(12):2013-25. PubMed ID: 21319793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and activity of NOX5 in the circulating malignant B cells of hairy cell leukemia.
    Kamiguti AS; Serrander L; Lin K; Harris RJ; Cawley JC; Allsup DJ; Slupsky JR; Krause KH; Zuzel M
    J Immunol; 2005 Dec; 175(12):8424-30. PubMed ID: 16339585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Nox homologues in the vasculature: focusing on Nox4 and Nox5.
    Montezano AC; Burger D; Ceravolo GS; Yusuf H; Montero M; Touyz RM
    Clin Sci (Lond); 2011 Feb; 120(4):131-41. PubMed ID: 21039341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure, regulation and evolution of Nox-family NADPH oxidases that produce reactive oxygen species.
    Sumimoto H
    FEBS J; 2008 Jul; 275(13):3249-77. PubMed ID: 18513324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of NADPH oxidase subunit NCF4 induces ROS-mediated EMT signaling in HeLa cells.
    Kim YM; Cho M
    Cell Signal; 2014 Apr; 26(4):784-96. PubMed ID: 24378533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NOX5-L can stimulate proliferation and apoptosis depending on its levels and cellular context, determining cancer cell susceptibility to cisplatin.
    Dho SH; Kim JY; Kwon ES; Lim JC; Park SS; Kwon KS
    Oncotarget; 2015 Nov; 6(36):39235-46. PubMed ID: 26513170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzymatic regulation and functional relevance of NOX5.
    Chen F; Wang Y; Barman S; Fulton DJ
    Curr Pharm Des; 2015; 21(41):5999-6008. PubMed ID: 26510438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NADPH oxidase 5 and renal disease.
    Holterman CE; Thibodeau JF; Kennedy CR
    Curr Opin Nephrol Hypertens; 2015 Jan; 24(1):81-7. PubMed ID: 25415612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Nox5 polymorphisms on basal and stimulus-dependent ROS generation.
    Wang Y; Chen F; Le B; Stepp DW; Fulton DJ
    PLoS One; 2014; 9(7):e100102. PubMed ID: 24992705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.